OnKure Therapeutics, Inc. (OKUR)
NGM – Real Time Price. Currency in USD
4.05
-0.04 (-0.98%)
Market open: Aug 12, 2026, 12:04 PM EDT
4.09
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
4.05
-0.04 (-0.98%)
Market open: Aug 12, 2026, 12:04 PM EDT
4.09
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $166.5M significantly exceed its total debt $926.0K, ensuring strong financial flexibility
Total current assets $177.7M exceed Total current liabilities $6.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$10.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 26.75 | 6.05 | 10 | |
| Quick ratio | 26.75 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -529K | -560K | -662K | -830K | -797K |
| Operating Income | -54M | -37M | -54M | -63M | -62M |
| Net Income | -52M | -35M | -53M | -60M | -59M |
| EBITDA | -53M | -36M | -53M | -62M | -61M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 53.21 | 5.5 |
| Next quarter | N/A | 45.71 | 5.5 |
| Current year | N/A | 48.64 | 5.5 |
| Next year | 33.33 | 13.27 | 9.0 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -1.24 | 72.07 | 19.98 | 7.5 |
| Y/Y | 999 | 0.29 | 72.81 | 22.05 | 8.0 |
| 3y average | 999 | -10.02 | 30.57 | -7.11 | 5.5 |
| 5y average | 999 | -33 | 18.52 | -30.39 | 5.3 |
| Weighted average score | 6.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |